Literature DB >> 23500414

Angiopoietin signaling in the vasculature.

Lauri Eklund1, Pipsa Saharinen.   

Abstract

The angiopoietin (Ang) growth factors and the endothelial Tie receptors regulate blood and lymphatic vessel development, and vascular permeability, inflammation, angiogenic remodeling and tumor vascularization in adult tissues. The angiopoietins activate the Tie receptors in unique in trans complexes at endothelial cell-cell and cell-matrix contacts. In addition, integrins have been implicated in the regulation of Ang-Tie signaling. Recent interest has focused on the function of angiopoietin-2 and its inhibition in the tumor vasculature and also in other pathological conditions associated with endothelial dysfunction. Here we review the current understanding of the signaling functions of the Ang-Tie pathway and its potential for future development of targeted vascular therapeutics.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500414     DOI: 10.1016/j.yexcr.2013.03.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  88 in total

Review 1.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

Authors:  Jonathan Welti; Sonja Loges; Stefanie Dimmeler; Peter Carmeliet
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

2.  The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases.

Authors:  Takashi Minami; Shuying Jiang; Keri Schadler; Jun-Ichi Suehiro; Tsuyoshi Osawa; Yuichi Oike; Mai Miura; Makoto Naito; Tatsuhiko Kodama; Sandra Ryeom
Journal:  Cell Rep       Date:  2013-08-15       Impact factor: 9.423

Review 3.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 4.  Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome.

Authors:  Jeffrey E Gotts; Michael A Matthay
Journal:  Clin Chest Med       Date:  2014-09-24       Impact factor: 2.878

5.  Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Authors:  Rena C Zuo; Andrea B Apolo; John J DiGiovanna; Howard L Parnes; Corrine M Keen; Swati Nanda; William L Dahut; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-02       Impact factor: 10.282

6.  Genomic and Genetic Approaches to Deciphering Acute Respiratory Distress Syndrome Risk and Mortality.

Authors:  Heather Lynn; Xiaoguang Sun; Nancy Casanova; Manuel Gonzales-Garay; Christian Bime; Joe G N Garcia
Journal:  Antioxid Redox Signal       Date:  2019-06-18       Impact factor: 8.401

7.  ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery.

Authors:  Haochen Xu; Yongliang Cao; Xing Yang; Ping Cai; Lijing Kang; Ximin Zhu; Haiyu Luo; Lu Lu; Lixiang Wei; Xiaofei Bai; Yuanbo Zhu; Bing-Qiao Zhao; Wenying Fan
Journal:  Blood       Date:  2017-04-20       Impact factor: 22.113

8.  Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma.

Authors:  Riccardo Rizzo; Maria Alvaro; Norbert Danz; Lucia Napione; Emiliano Descrovi; Stefan Schmieder; Alberto Sinibaldi; Subinoy Rana; Rona Chandrawati; Peter Munzert; Thomas Schubert; Emmanuel Maillart; Aleksei Anopchenko; Paola Rivolo; Alessandro Mascioletti; Erik Förster; Frank Sonntag; Molly M Stevens; Federico Bussolino; Francesco Michelotti
Journal:  Biomed Opt Express       Date:  2018-01-08       Impact factor: 3.732

9.  Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

Authors:  Gabriela D'Amico; Emilia A Korhonen; Andrey Anisimov; Georgia Zarkada; Tanja Holopainen; René Hägerling; Friedemann Kiefer; Lauri Eklund; Raija Sormunen; Harri Elamaa; Rolf A Brekken; Ralf H Adams; Gou Young Koh; Pipsa Saharinen; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

10.  Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

Authors:  Elisa Boscolo; Nisha Limaye; Lan Huang; Kyu-Tae Kang; Julie Soblet; Melanie Uebelhoer; Antonella Mendola; Marjut Natynki; Emmanuel Seront; Sophie Dupont; Jennifer Hammer; Catherine Legrand; Carlo Brugnara; Lauri Eklund; Miikka Vikkula; Joyce Bischoff; Laurence M Boon
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.